Pharma & Healthcare
Global Conjugate Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437541
- Pages: 80
- Figures: 80
- Views: 3
The global Conjugate Vaccine market is strategically segmented by company, region (country), by Type, and by End Users. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by End Users for 2020-2031.
Market Segmentation
By Company:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Beijing Minhai Biotechnology
SinoPharma
By Type: (Dominant Segment vs High-Margin Innovation)
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Children
Adult
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer in Europe)
- Emerging Product Trends: Hib Vaccine adoption vs. Meningococcal Vaccine premiumization
- Demand-Side Dynamics: Children growth in China vs. Adult potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Conjugate Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Meningococcal Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Adult in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Hib Vaccine dominance in Europe vs. Meningococcal Vaccine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Beijing Minhai Biotechnology
SinoPharma
By Type: (Dominant Segment vs High-Margin Innovation)
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Children
Adult
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer in Europe)
- Emerging Product Trends: Hib Vaccine adoption vs. Meningococcal Vaccine premiumization
- Demand-Side Dynamics: Children growth in China vs. Adult potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Conjugate Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Meningococcal Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Adult in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Hib Vaccine dominance in Europe vs. Meningococcal Vaccine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Conjugate Vaccine Product Scope
1.2 Conjugate Vaccine by Type
1.2.1 Global Conjugate Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine by End Users
1.3.1 Global Conjugate Vaccine Sales Comparison by End Users (2020 & 2024 & 2031)
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Conjugate Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Conjugate Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Conjugate Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Conjugate Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Conjugate Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Conjugate Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Conjugate Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Conjugate Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Conjugate Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Conjugate Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.5 Southeast Asia Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.6 India Conjugate Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Conjugate Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Conjugate Vaccine Sales by Type (2020-2025)
3.1.2 Global Conjugate Vaccine Revenue by Type (2020-2025)
3.1.3 Global Conjugate Vaccine Price by Type (2020-2025)
3.2 Global Conjugate Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Conjugate Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Conjugate Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Conjugate Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Conjugate Vaccine Representative Players
4 Global Market Size by End Users
4.1 Global Conjugate Vaccine Historic Market Review by End Users (2020-2025)
4.1.1 Global Conjugate Vaccine Sales by End Users (2020-2025)
4.1.2 Global Conjugate Vaccine Revenue by End Users (2020-2025)
4.1.3 Global Conjugate Vaccine Price by End Users (2020-2025)
4.2 Global Conjugate Vaccine Market Estimates and Forecasts by End Users (2026-2031)
4.2.1 Global Conjugate Vaccine Sales Forecast by End Users (2026-2031)
4.2.2 Global Conjugate Vaccine Revenue Forecast by End Users (2026-2031)
4.2.3 Global Conjugate Vaccine Price Forecast by End Users (2026-2031)
4.3 New Sources of Growth in Conjugate Vaccine Application
5 Competition Landscape by Players
5.1 Global Conjugate Vaccine Sales by Players (2020-2025)
5.2 Global Top Conjugate Vaccine Players by Revenue (2020-2025)
5.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
5.4 Global Conjugate Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Conjugate Vaccine Sales by Company
6.1.1.1 North America Conjugate Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Conjugate Vaccine Revenue by Company (2020-2025)
6.1.2 North America Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.1.4 North America Conjugate Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Conjugate Vaccine Sales by Company
6.2.1.1 Europe Conjugate Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Conjugate Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.2.4 Europe Conjugate Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Conjugate Vaccine Sales by Company
6.3.1.1 China Conjugate Vaccine Sales by Company (2020-2025)
6.3.1.2 China Conjugate Vaccine Revenue by Company (2020-2025)
6.3.2 China Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.3.4 China Conjugate Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Conjugate Vaccine Sales by Company
6.4.1.1 Japan Conjugate Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan Conjugate Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.4.4 Japan Conjugate Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Conjugate Vaccine Sales by Company
6.5.1.1 Southeast Asia Conjugate Vaccine Sales by Company (2020-2025)
6.5.1.2 Southeast Asia Conjugate Vaccine Revenue by Company (2020-2025)
6.5.2 Southeast Asia Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.5.3 Southeast Asia Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.5.4 Southeast Asia Conjugate Vaccine Major Customer
6.5.5 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Conjugate Vaccine Sales by Company
6.6.1.1 India Conjugate Vaccine Sales by Company (2020-2025)
6.6.1.2 India Conjugate Vaccine Revenue by Company (2020-2025)
6.6.2 India Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.6.3 India Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.6.4 India Conjugate Vaccine Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Conjugate Vaccine Products Offered
7.1.5 Pfizer Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Business Overview
7.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GSK Conjugate Vaccine Products Offered
7.2.5 GSK Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi Conjugate Vaccine Products Offered
7.3.5 Sanofi Recent Development
7.4 Merck
7.4.1 Merck Company Information
7.4.2 Merck Business Overview
7.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Merck Conjugate Vaccine Products Offered
7.4.5 Merck Recent Development
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Company Information
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered
7.5.5 Walvax Biotechnology Recent Development
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
7.7 Bharat Biotech
7.7.1 Bharat Biotech Company Information
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Bharat Biotech Conjugate Vaccine Products Offered
7.7.5 Bharat Biotech Recent Development
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Company Information
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhifei Biologic Conjugate Vaccine Products Offered
7.8.5 Zhifei Biologic Recent Development
7.9 Beijing Minhai Biotechnology
7.9.1 Beijing Minhai Biotechnology Company Information
7.9.2 Beijing Minhai Biotechnology Business Overview
7.9.3 Beijing Minhai Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Beijing Minhai Biotechnology Conjugate Vaccine Products Offered
7.9.5 Beijing Minhai Biotechnology Recent Development
7.10 SinoPharma
7.10.1 SinoPharma Company Information
7.10.2 SinoPharma Business Overview
7.10.3 SinoPharma Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 SinoPharma Conjugate Vaccine Products Offered
7.10.5 SinoPharma Recent Development
8 Conjugate Vaccine Manufacturing Cost Analysis
8.1 Conjugate Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Conjugate Vaccine
8.4 Conjugate Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Conjugate Vaccine Distributors List
9.3 Conjugate Vaccine Customers
10 Conjugate Vaccine Market Dynamics
10.1 Conjugate Vaccine Industry Trends
10.2 Conjugate Vaccine Market Drivers
10.3 Conjugate Vaccine Market Challenges
10.4 Conjugate Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Conjugate Vaccine Product Scope
1.2 Conjugate Vaccine by Type
1.2.1 Global Conjugate Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine by End Users
1.3.1 Global Conjugate Vaccine Sales Comparison by End Users (2020 & 2024 & 2031)
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Conjugate Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Conjugate Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Conjugate Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Conjugate Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Conjugate Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Conjugate Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Conjugate Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Conjugate Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Conjugate Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Conjugate Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.5 Southeast Asia Conjugate Vaccine Market Size and Prospective (2020-2031)
2.4.6 India Conjugate Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Conjugate Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Conjugate Vaccine Sales by Type (2020-2025)
3.1.2 Global Conjugate Vaccine Revenue by Type (2020-2025)
3.1.3 Global Conjugate Vaccine Price by Type (2020-2025)
3.2 Global Conjugate Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Conjugate Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Conjugate Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Conjugate Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Conjugate Vaccine Representative Players
4 Global Market Size by End Users
4.1 Global Conjugate Vaccine Historic Market Review by End Users (2020-2025)
4.1.1 Global Conjugate Vaccine Sales by End Users (2020-2025)
4.1.2 Global Conjugate Vaccine Revenue by End Users (2020-2025)
4.1.3 Global Conjugate Vaccine Price by End Users (2020-2025)
4.2 Global Conjugate Vaccine Market Estimates and Forecasts by End Users (2026-2031)
4.2.1 Global Conjugate Vaccine Sales Forecast by End Users (2026-2031)
4.2.2 Global Conjugate Vaccine Revenue Forecast by End Users (2026-2031)
4.2.3 Global Conjugate Vaccine Price Forecast by End Users (2026-2031)
4.3 New Sources of Growth in Conjugate Vaccine Application
5 Competition Landscape by Players
5.1 Global Conjugate Vaccine Sales by Players (2020-2025)
5.2 Global Top Conjugate Vaccine Players by Revenue (2020-2025)
5.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
5.4 Global Conjugate Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Conjugate Vaccine Sales by Company
6.1.1.1 North America Conjugate Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Conjugate Vaccine Revenue by Company (2020-2025)
6.1.2 North America Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.1.4 North America Conjugate Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Conjugate Vaccine Sales by Company
6.2.1.1 Europe Conjugate Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Conjugate Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.2.4 Europe Conjugate Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Conjugate Vaccine Sales by Company
6.3.1.1 China Conjugate Vaccine Sales by Company (2020-2025)
6.3.1.2 China Conjugate Vaccine Revenue by Company (2020-2025)
6.3.2 China Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.3.4 China Conjugate Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Conjugate Vaccine Sales by Company
6.4.1.1 Japan Conjugate Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan Conjugate Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.4.4 Japan Conjugate Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Conjugate Vaccine Sales by Company
6.5.1.1 Southeast Asia Conjugate Vaccine Sales by Company (2020-2025)
6.5.1.2 Southeast Asia Conjugate Vaccine Revenue by Company (2020-2025)
6.5.2 Southeast Asia Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.5.3 Southeast Asia Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.5.4 Southeast Asia Conjugate Vaccine Major Customer
6.5.5 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Conjugate Vaccine Sales by Company
6.6.1.1 India Conjugate Vaccine Sales by Company (2020-2025)
6.6.1.2 India Conjugate Vaccine Revenue by Company (2020-2025)
6.6.2 India Conjugate Vaccine Sales Breakdown by Type (2020-2025)
6.6.3 India Conjugate Vaccine Sales Breakdown by End Users (2020-2025)
6.6.4 India Conjugate Vaccine Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Conjugate Vaccine Products Offered
7.1.5 Pfizer Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Business Overview
7.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GSK Conjugate Vaccine Products Offered
7.2.5 GSK Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi Conjugate Vaccine Products Offered
7.3.5 Sanofi Recent Development
7.4 Merck
7.4.1 Merck Company Information
7.4.2 Merck Business Overview
7.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Merck Conjugate Vaccine Products Offered
7.4.5 Merck Recent Development
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Company Information
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered
7.5.5 Walvax Biotechnology Recent Development
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
7.7 Bharat Biotech
7.7.1 Bharat Biotech Company Information
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Bharat Biotech Conjugate Vaccine Products Offered
7.7.5 Bharat Biotech Recent Development
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Company Information
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhifei Biologic Conjugate Vaccine Products Offered
7.8.5 Zhifei Biologic Recent Development
7.9 Beijing Minhai Biotechnology
7.9.1 Beijing Minhai Biotechnology Company Information
7.9.2 Beijing Minhai Biotechnology Business Overview
7.9.3 Beijing Minhai Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Beijing Minhai Biotechnology Conjugate Vaccine Products Offered
7.9.5 Beijing Minhai Biotechnology Recent Development
7.10 SinoPharma
7.10.1 SinoPharma Company Information
7.10.2 SinoPharma Business Overview
7.10.3 SinoPharma Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 SinoPharma Conjugate Vaccine Products Offered
7.10.5 SinoPharma Recent Development
8 Conjugate Vaccine Manufacturing Cost Analysis
8.1 Conjugate Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Conjugate Vaccine
8.4 Conjugate Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Conjugate Vaccine Distributors List
9.3 Conjugate Vaccine Customers
10 Conjugate Vaccine Market Dynamics
10.1 Conjugate Vaccine Industry Trends
10.2 Conjugate Vaccine Market Drivers
10.3 Conjugate Vaccine Market Challenges
10.4 Conjugate Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Conjugate Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Conjugate Vaccine Sales (US$ Million) Comparison by End Users (2020 & 2024 & 2031)
Table 3. Global Market Conjugate Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Conjugate Vaccine Sales (Million Unit) by Region (2020-2025)
Table 5. Global Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 6. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Conjugate Vaccine Revenue Share by Region (2020-2025)
Table 8. Global Conjugate Vaccine Sales (Million Unit) Forecast by Region (2026-2031)
Table 9. Global Conjugate Vaccine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Conjugate Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Conjugate Vaccine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Conjugate Vaccine Sales by Type (Million Unit) & (2020-2025)
Table 13. Global Conjugate Vaccine Sales Share by Type (2020-2025)
Table 14. Global Conjugate Vaccine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Conjugate Vaccine Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Conjugate Vaccine Sales by Type (Million Unit) & (2026-2031)
Table 17. Global Conjugate Vaccine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Conjugate Vaccine Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Conjugate Vaccine Sales by End Users (Million Unit) & (2020-2025)
Table 21. Global Conjugate Vaccine Sales Share by End Users (2020-2025)
Table 22. Global Conjugate Vaccine Revenue by End Users (US$ Million) & (2020-2025)
Table 23. Global Conjugate Vaccine Price by End Users (USD/Unit) & (2020-2025)
Table 24. Global Conjugate Vaccine Sales by End Users (Million Unit) & (2026-2031)
Table 25. Global Conjugate Vaccine Revenue Market Share by End Users (US$ Million) & (2026-2031)
Table 26. Global Conjugate Vaccine Price by End Users (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Conjugate Vaccine Application
Table 28. Global Conjugate Vaccine Sales by Company (Million Unit) & (2020-2025)
Table 29. Global Conjugate Vaccine Sales Share by Company (2020-2025)
Table 30. Global Conjugate Vaccine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Conjugate Vaccine Revenue Share by Company (2020-2025)
Table 32. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
Table 33. Global Market Conjugate Vaccine Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
Table 36. Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 39. North America Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 40. North America Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 42. North America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 43. North America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 44. North America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 45. North America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 46. Europe Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 47. Europe Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 48. Europe Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 50. Europe Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 51. Europe Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 52. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 53. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 54. China Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 55. China Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 56. China Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 58. China Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 59. China Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 60. China Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 61. China Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 62. Japan Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 63. Japan Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 64. Japan Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 66. Japan Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 67. Japan Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 68. Japan Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 69. Japan Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 70. Southeast Asia Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 71. Southeast Asia Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 72. Southeast Asia Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 73. Southeast Asia Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 74. Southeast Asia Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 75. Southeast Asia Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 76. Southeast Asia Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 77. Southeast Asia Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 78. India Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 79. India Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 80. India Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 82. India Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 83. India Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 84. India Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 85. India Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 86. Pfizer Company Information
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Pfizer Conjugate Vaccine Product
Table 90. Pfizer Recent Development
Table 91. GSK Company Information
Table 92. GSK Description and Business Overview
Table 93. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. GSK Conjugate Vaccine Product
Table 95. GSK Recent Development
Table 96. Sanofi Company Information
Table 97. Sanofi Description and Business Overview
Table 98. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Sanofi Conjugate Vaccine Product
Table 100. Sanofi Recent Development
Table 101. Merck Company Information
Table 102. Merck Description and Business Overview
Table 103. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Merck Conjugate Vaccine Product
Table 105. Merck Recent Development
Table 106. Walvax Biotechnology Company Information
Table 107. Walvax Biotechnology Description and Business Overview
Table 108. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Walvax Biotechnology Conjugate Vaccine Product
Table 110. Walvax Biotechnology Recent Development
Table 111. Royal (Wuxi) Bio-Pharmaceutical Company Information
Table 112. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 113. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 115. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 116. Bharat Biotech Company Information
Table 117. Bharat Biotech Description and Business Overview
Table 118. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Bharat Biotech Conjugate Vaccine Product
Table 120. Bharat Biotech Recent Development
Table 121. Zhifei Biologic Company Information
Table 122. Zhifei Biologic Description and Business Overview
Table 123. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Zhifei Biologic Conjugate Vaccine Product
Table 125. Zhifei Biologic Recent Development
Table 126. Beijing Minhai Biotechnology Company Information
Table 127. Beijing Minhai Biotechnology Description and Business Overview
Table 128. Beijing Minhai Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Beijing Minhai Biotechnology Conjugate Vaccine Product
Table 130. Beijing Minhai Biotechnology Recent Development
Table 131. SinoPharma Company Information
Table 132. SinoPharma Description and Business Overview
Table 133. SinoPharma Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. SinoPharma Conjugate Vaccine Product
Table 135. SinoPharma Recent Development
Table 136. Production Base and Market Concentration Rate of Raw Material
Table 137. Key Suppliers of Raw Materials
Table 138. Conjugate Vaccine Distributors List
Table 139. Conjugate Vaccine Customers List
Table 140. Conjugate Vaccine Market Trends
Table 141. Conjugate Vaccine Market Drivers
Table 142. Conjugate Vaccine Market Challenges
Table 143. Conjugate Vaccine Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Conjugate Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Sales (US$ Million) by End Users (2020 & 2024 & 2031)
Figure 9. Global Conjugate Vaccine Sales Market Share by End Users in 2024 & 2031
Figure 10. Children Examples
Figure 11. Adult Examples
Figure 12. Global Conjugate Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Conjugate Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 15. Global Conjugate Vaccine Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 16. Conjugate Vaccine Report Years Considered
Figure 17. Global Market Conjugate Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Conjugate Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 21. Europe Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 23. China Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 25. Japan Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 27. Southeast Asia Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Southeast Asia Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 29. India Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. India Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 31. Global Conjugate Vaccine Revenue Share by Type (2020-2025)
Figure 32. Global Conjugate Vaccine Sales Share by Type (2026-2031)
Figure 33. Global Conjugate Vaccine Revenue Share by Type (2026-2031)
Figure 34. Global Conjugate Vaccine Revenue Share by End Users (2020-2025)
Figure 35. Global Conjugate Vaccine Revenue Growth Rate by End Users in 2020 & 2024
Figure 36. Global Conjugate Vaccine Sales Share by End Users (2026-2031)
Figure 37. Global Conjugate Vaccine Revenue Share by End Users (2026-2031)
Figure 38. Global Conjugate Vaccine Sales Share by Company (2024)
Figure 39. Global Conjugate Vaccine Revenue Share by Company (2024)
Figure 40. Global 5 Largest Conjugate Vaccine Players Market Share by Revenue in Conjugate Vaccine: 2020 & 2024
Figure 41. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 42. Manufacturing Cost Structure of Conjugate Vaccine
Figure 43. Manufacturing Process Analysis of Conjugate Vaccine
Figure 44. Conjugate Vaccine Industrial Chain
Figure 45. Channels of Distribution (Direct Vs Distribution)
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Table 1. Global Conjugate Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Conjugate Vaccine Sales (US$ Million) Comparison by End Users (2020 & 2024 & 2031)
Table 3. Global Market Conjugate Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Conjugate Vaccine Sales (Million Unit) by Region (2020-2025)
Table 5. Global Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 6. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Conjugate Vaccine Revenue Share by Region (2020-2025)
Table 8. Global Conjugate Vaccine Sales (Million Unit) Forecast by Region (2026-2031)
Table 9. Global Conjugate Vaccine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Conjugate Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Conjugate Vaccine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Conjugate Vaccine Sales by Type (Million Unit) & (2020-2025)
Table 13. Global Conjugate Vaccine Sales Share by Type (2020-2025)
Table 14. Global Conjugate Vaccine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Conjugate Vaccine Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Conjugate Vaccine Sales by Type (Million Unit) & (2026-2031)
Table 17. Global Conjugate Vaccine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Conjugate Vaccine Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Conjugate Vaccine Sales by End Users (Million Unit) & (2020-2025)
Table 21. Global Conjugate Vaccine Sales Share by End Users (2020-2025)
Table 22. Global Conjugate Vaccine Revenue by End Users (US$ Million) & (2020-2025)
Table 23. Global Conjugate Vaccine Price by End Users (USD/Unit) & (2020-2025)
Table 24. Global Conjugate Vaccine Sales by End Users (Million Unit) & (2026-2031)
Table 25. Global Conjugate Vaccine Revenue Market Share by End Users (US$ Million) & (2026-2031)
Table 26. Global Conjugate Vaccine Price by End Users (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Conjugate Vaccine Application
Table 28. Global Conjugate Vaccine Sales by Company (Million Unit) & (2020-2025)
Table 29. Global Conjugate Vaccine Sales Share by Company (2020-2025)
Table 30. Global Conjugate Vaccine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Conjugate Vaccine Revenue Share by Company (2020-2025)
Table 32. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2024)
Table 33. Global Market Conjugate Vaccine Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
Table 36. Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 39. North America Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 40. North America Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 42. North America Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 43. North America Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 44. North America Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 45. North America Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 46. Europe Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 47. Europe Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 48. Europe Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 50. Europe Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 51. Europe Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 52. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 53. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 54. China Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 55. China Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 56. China Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 58. China Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 59. China Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 60. China Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 61. China Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 62. Japan Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 63. Japan Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 64. Japan Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 66. Japan Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 67. Japan Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 68. Japan Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 69. Japan Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 70. Southeast Asia Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 71. Southeast Asia Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 72. Southeast Asia Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 73. Southeast Asia Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 74. Southeast Asia Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 75. Southeast Asia Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 76. Southeast Asia Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 77. Southeast Asia Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 78. India Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 79. India Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 80. India Conjugate Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 82. India Conjugate Vaccine Sales by Type (2020-2025) & (Million Unit)
Table 83. India Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 84. India Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 85. India Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Table 86. Pfizer Company Information
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Pfizer Conjugate Vaccine Product
Table 90. Pfizer Recent Development
Table 91. GSK Company Information
Table 92. GSK Description and Business Overview
Table 93. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. GSK Conjugate Vaccine Product
Table 95. GSK Recent Development
Table 96. Sanofi Company Information
Table 97. Sanofi Description and Business Overview
Table 98. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Sanofi Conjugate Vaccine Product
Table 100. Sanofi Recent Development
Table 101. Merck Company Information
Table 102. Merck Description and Business Overview
Table 103. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Merck Conjugate Vaccine Product
Table 105. Merck Recent Development
Table 106. Walvax Biotechnology Company Information
Table 107. Walvax Biotechnology Description and Business Overview
Table 108. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Walvax Biotechnology Conjugate Vaccine Product
Table 110. Walvax Biotechnology Recent Development
Table 111. Royal (Wuxi) Bio-Pharmaceutical Company Information
Table 112. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 113. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 115. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 116. Bharat Biotech Company Information
Table 117. Bharat Biotech Description and Business Overview
Table 118. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Bharat Biotech Conjugate Vaccine Product
Table 120. Bharat Biotech Recent Development
Table 121. Zhifei Biologic Company Information
Table 122. Zhifei Biologic Description and Business Overview
Table 123. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Zhifei Biologic Conjugate Vaccine Product
Table 125. Zhifei Biologic Recent Development
Table 126. Beijing Minhai Biotechnology Company Information
Table 127. Beijing Minhai Biotechnology Description and Business Overview
Table 128. Beijing Minhai Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Beijing Minhai Biotechnology Conjugate Vaccine Product
Table 130. Beijing Minhai Biotechnology Recent Development
Table 131. SinoPharma Company Information
Table 132. SinoPharma Description and Business Overview
Table 133. SinoPharma Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. SinoPharma Conjugate Vaccine Product
Table 135. SinoPharma Recent Development
Table 136. Production Base and Market Concentration Rate of Raw Material
Table 137. Key Suppliers of Raw Materials
Table 138. Conjugate Vaccine Distributors List
Table 139. Conjugate Vaccine Customers List
Table 140. Conjugate Vaccine Market Trends
Table 141. Conjugate Vaccine Market Drivers
Table 142. Conjugate Vaccine Market Challenges
Table 143. Conjugate Vaccine Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Conjugate Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Sales (US$ Million) by End Users (2020 & 2024 & 2031)
Figure 9. Global Conjugate Vaccine Sales Market Share by End Users in 2024 & 2031
Figure 10. Children Examples
Figure 11. Adult Examples
Figure 12. Global Conjugate Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Conjugate Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 15. Global Conjugate Vaccine Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 16. Conjugate Vaccine Report Years Considered
Figure 17. Global Market Conjugate Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Conjugate Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 21. Europe Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 23. China Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 25. Japan Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 27. Southeast Asia Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Southeast Asia Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 29. India Conjugate Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. India Conjugate Vaccine Sales (Million Unit) Growth Rate (2020-2031)
Figure 31. Global Conjugate Vaccine Revenue Share by Type (2020-2025)
Figure 32. Global Conjugate Vaccine Sales Share by Type (2026-2031)
Figure 33. Global Conjugate Vaccine Revenue Share by Type (2026-2031)
Figure 34. Global Conjugate Vaccine Revenue Share by End Users (2020-2025)
Figure 35. Global Conjugate Vaccine Revenue Growth Rate by End Users in 2020 & 2024
Figure 36. Global Conjugate Vaccine Sales Share by End Users (2026-2031)
Figure 37. Global Conjugate Vaccine Revenue Share by End Users (2026-2031)
Figure 38. Global Conjugate Vaccine Sales Share by Company (2024)
Figure 39. Global Conjugate Vaccine Revenue Share by Company (2024)
Figure 40. Global 5 Largest Conjugate Vaccine Players Market Share by Revenue in Conjugate Vaccine: 2020 & 2024
Figure 41. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 42. Manufacturing Cost Structure of Conjugate Vaccine
Figure 43. Manufacturing Process Analysis of Conjugate Vaccine
Figure 44. Conjugate Vaccine Industrial Chain
Figure 45. Channels of Distribution (Direct Vs Distribution)
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232